These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28471528)

  • 21. Meeting of the International Task Force for Disease Eradication, November 2015.
    Wkly Epidemiol Rec; 2016 Feb; 91(6):61-71. PubMed ID: 26875204
    [No Abstract]   [Full Text] [Related]  

  • 22. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.
    Deblina Datta S; Tangermann RH; Reef S; William Schluter W; Adams A
    J Infect Dis; 2017 Jul; 216(suppl_1):S351-S354. PubMed ID: 28838172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles and rubella eradication.
    Hinman AR
    Vaccine; 2018 Jan; 36(1):1-3. PubMed ID: 29183733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roadmap to elimination standard measles and rubella surveillance.
    Wkly Epidemiol Rec; 2017 Mar; 92(9-10):97-105. PubMed ID: 28262010
    [No Abstract]   [Full Text] [Related]  

  • 26. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT; Lessler J; Metcalf CJ
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliminating measles and rubella in Europe.
    Allerberger F
    Clin Microbiol Infect; 2017 Aug; 23(8):502-503. PubMed ID: 28412385
    [No Abstract]   [Full Text] [Related]  

  • 28. A Moral Imperative to Eradicate Measles, Rubella.
    Archer Kelser E
    Health Prog; 2017; 98(1):19-25. PubMed ID: 30036003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global measles and rubella laboratory network--update.
    World Health Organization
    Wkly Epidemiol Rec; 2005 Nov; 80(44):384-8. PubMed ID: 16300026
    [No Abstract]   [Full Text] [Related]  

  • 30. Measles and rubella elimination in the WHO Region for Europe: progress and challenges.
    O'Connor P; Jankovic D; Muscat M; Ben-Mamou M; Reef S; Papania M; Singh S; Kaloumenos T; Butler R; Datta S
    Clin Microbiol Infect; 2017 Aug; 23(8):504-510. PubMed ID: 28111293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Norway be kept free from rubella and measles?
    Riise ØR; Rønning K; Dudman SG; Sandbu S
    Tidsskr Nor Laegeforen; 2017 Aug; 137(14-15):. PubMed ID: 28828847
    [No Abstract]   [Full Text] [Related]  

  • 32. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
    Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M
    Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015.
    Kriss JL; Stanescu A; Pistol A; Butu C; Goodson JL
    Risk Anal; 2017 Jun; 37(6):1096-1107. PubMed ID: 27439071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A measles eradication goal is upon us; can rubella and congenital rubella syndrome be far behind?
    Sniadack DH; Orenstein WA
    Vaccine; 2013 May; 31(24):2659-60. PubMed ID: 23602539
    [No Abstract]   [Full Text] [Related]  

  • 35. Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.
    Grant GB; Masresha BG; Moss WJ; Mulders MN; Rota PA; Omer SB; Shefer A; Kriss JL; Hanson M; Durrheim DN; Linkins R; Goodson JL
    Vaccine; 2019 Sep; 37(38):5754-5761. PubMed ID: 30904317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1100-4. PubMed ID: 16267497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe].
    Garcés-Sánchez M; Renales-Toboso M; Bóveda-García M; Díez-Domingo J
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):673-8. PubMed ID: 26611100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imported measles and rubella pose threat to US elimination of the diseases, says CDC report.
    McCarthy M
    BMJ; 2013 Dec; 347():f7373. PubMed ID: 24324216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.